Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Publication year range
1.
Clin Neurol Neurosurg ; 196: 106011, 2020 09.
Article in English | MEDLINE | ID: mdl-32593044

ABSTRACT

BACKGROUND: Coccidioidal meningitis is a life-threatening condition and a diagnostic challenge in cases of chronic meningitis. It is associated to severe complications, like basal arachnoiditis, hydrocephalus, and secondary vasculitis. OBJECTIVE: To present a 20-year retrospective clinical series of coccidioidal meningitis cases at a Mexican neurological referral center. RESULTS: The clinical records of 11 patients, predominantly males, were retrieved. Weight loss and night sweats were observed in 64 % of cases. Neurological signs included intracranial hypertension in 91 % of cases, altered alertness and meningeal syndrome in 72 %, and neuropsychiatric symptoms in 64 %. Mean CSF glucose levels were 30 ± 25 mg/dL, and pleocytosis ranged from 0 to 2218 cells/mm3. The diagnosis was confirmed by coccidioidal antigen latex agglutination in 91 % of cases. Radiological findings were hepatomegaly in 55 % of cases and pneumonia in 45 %. Neuroimaging findings included leptomeningitis in 73 % of cases, pachymeningitis in 45 %, and vascular involvement in 91 %. Less common findings included spinal cord lesion and mycotic aneurism, found in 18 % of cases. A molecular coccidioidal DNA test confirmed the predominance of Coccidioides immitis, detected in 64 % of cases. With respect to the clinical outcome, 46 % of patients died. The survivors suffered from sequels like chronic headache, cognitive alterations, and depression. CONCLUSIONS: Coccidioidal meningitis is an entity with high mortality rates. More than one half of patients suffered disseminated disease. Although meningeal signs are not frequent in chronic meningitis, more than two-thirds of our patients showed mild nuchal rigidity. In addition, cerebral and cerebellar volume loss, associated with cognitive impairment and depression, was often observed in surviving patients during the clinical-radiological follow-up.


Subject(s)
Antifungal Agents/therapeutic use , Brain/diagnostic imaging , Coccidioidomycosis/drug therapy , Hypertension/etiology , Meningitis, Fungal/drug therapy , Adult , Coccidioides/isolation & purification , Coccidioidomycosis/complications , Coccidioidomycosis/diagnostic imaging , Female , Humans , Hypertension/diagnostic imaging , Male , Meningitis, Fungal/complications , Meningitis, Fungal/diagnostic imaging , Mexico , Middle Aged , Neuroimaging , Retrospective Studies , Treatment Outcome , Young Adult
2.
Clin Neurol Neurosurg ; 188: 105592, 2020 01.
Article in English | MEDLINE | ID: mdl-31760254

ABSTRACT

A 38-year-old male presented to the hospital with headache, fever, and meningeal signs. He had undergone a surgical review of a ventriculoperitoneal shunt system one month earlier. A head computed tomography scan showed hydrocephalus. His medical history included a human immunodeficiency virus infection identified four years before and resolved cryptococcal meningitis, which had necessitated the implantation of the shunt system. Ventricular cerebrospinal fluid (CSF) was obtained, which showed inflammation and, in culture, grew a Gram-negative bacillus identified as multidrug-resistant Klebsiella oxytoca. The shunt was removed and a ventricular drain was installed. Treatment with meropenem and amikacin was established without a response; the CSF white blood cell count continued to increase, with cultures remaining positive. The patient's clinical condition deteriorated to stupor. With informed consent, intraventricular (ITV) treatment with tigecycline was initiated at a dose of 5 mg every 24 h and, three days later, the CSF cultures were negativized. Tigecycline levels in the CSF were quantified by liquid chromatography with ultraviolet detection and showed peak concentrations achieved at two hours after the dose of between 178 and 310 µg/mL. After 11 days of treatment with ITV tigecycline and eight negative CSF cultures, a new CSF shunt was installed. During follow-up review 10 months later, the patient reported he was working. The dose of tigecycline used in this study produced levels 15 to 20 times the minimum inhibitory concentration of the bacteria for up to six hours with adequate tolerance.


Subject(s)
Anti-Bacterial Agents/therapeutic use , Cerebral Ventriculitis/drug therapy , Drug Resistance, Multiple, Bacterial , Klebsiella Infections/drug therapy , Surgical Wound Infection/drug therapy , Tigecycline/therapeutic use , Ventriculoperitoneal Shunt , Adult , Anti-Bacterial Agents/cerebrospinal fluid , Anti-HIV Agents/therapeutic use , Cerebral Ventriculitis/complications , Cerebral Ventriculitis/diagnosis , Cerebral Ventriculitis/microbiology , Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination/therapeutic use , HIV Infections/complications , HIV Infections/drug therapy , Humans , Injections, Intraventricular , Klebsiella Infections/complications , Klebsiella Infections/diagnosis , Klebsiella Infections/microbiology , Klebsiella oxytoca/isolation & purification , Klebsiella oxytoca/physiology , Male , Microbial Sensitivity Tests , Surgical Wound Infection/complications , Surgical Wound Infection/diagnosis , Surgical Wound Infection/microbiology , Tigecycline/cerebrospinal fluid
3.
Gac Med Mex ; 138(5): 397-404, 2002.
Article in Spanish | MEDLINE | ID: mdl-12404723

ABSTRACT

OBJECTIVE: To describe the results of 10 years of nosocomial infection (NI) surveillance at a neurological center and evaluate the impact of control measures. PATIENTS AND METHODS: A descriptive and retrospective study was performed at a reference center for adult neurologic and neurosurgical patients located in Mexico City. Between 1990 and 2000, the number, site and type of NI were registered. Chi Square test was employed for statistical analysis of numerical data. RESULTS: Mean NI rate observed was 21 episodes per 100 discharges, with a 40% reduction during the period. Predominant NI were urinary tract infections (36%), lower respiratory tract infections (31%), phlebitis (9%), primary bacteremia (7%), surgical wound infections (7%), and pneumonia (4%). Control measures with a definite impact were organization of intravenous therapy teams with reduction in bacteremia (p = 0.009). Changes in preoperative care, hair clipping instead of shaving, clorhexidine shampoo, and technique of long tunneled ventriculostomy with a 57% reduction (p = 0.00006) in infections related with neurosurgical procedures. The increase in staff and equipment renewal of the respiratory therapy service decreased respiratory infections. CONCLUSIONS: The measures that reduced our NI rate may be useful in other centers for neurologic patients.


Subject(s)
Cross Infection/epidemiology , Humans , Nervous System Diseases , Retrospective Studies , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...